跳至主要内容
临床试验/CTRI/2026/02/105006
CTRI/2026/02/105006尚未招募3 期

The effect of medicinal leech therapy on the improvement of dysmenorrhea an open labelled study

Government Nizamia Tibbi College1 个研究点 分布在 1 个国家目标入组 49 人开始时间: 2026年3月12日最近更新:
适应症
相关药物

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
49
试验地点
1
主要终点
reduction in pain intensity assessed by Visual Analogue Scale in each consecutive cycle

研究概览

简要总结

Dysmenorrhea is the most common gynaecological complaint in adolescent and young women which incapacitates day to day activities , which includes pelvic and non pelvic pathologies.

Title of the study : The Effect of Medicinal Leech Therapy on the improvement of Dysmenorrhea  An Open Labelled Study

Aim : To assess the effect of medicinal leech therapy on the improvement of dysmenorrhea.

Inclusion Criteria : Female patients in the age group of 16 to 40 years with primary and secondary dysmenorrhea.

Exclusion Criteria : The following patients will be excluded from the study

1.Age below 16 and above 40 years

2.Hypertension

3.Patients on anticoagulants

4.Congenital malformation of the genital tract

5.Pelvic malignancies

6.Pregnancy and lactation (upto 6 months)

7.Bleeding disorders like severe anaemia and thrombocytopenia

Sample size : 49

Intervention :Patient will receive leech therapy (2 leeches)  at the supra pubic region prior to the onset of menstruation based on the individual cycle for three consecutive cycles with each session lasting 30 minutes or until the leeches detaches spontaneously.

Outcomes : Primary outcome :

reduction in pain intensity assessed by VAS Scale

Secondary outcome

overall reduction in severity of dysmenorrhea and associated symptoms assessed by WaLIDD Score.

研究设计

研究类型
Interventional
分配方式
Other
盲法
None

入排标准

年龄范围
16.00 Year(s) 至 40.00 Year(s)(—)
性别
Female

入选标准

  • •patient with primary and secondary dysmenorrhea.

排除标准

  • •Congenital malformation of the genital tract Pelvic malignancy Bleeding disorders like anaemia less than 7 gm per dl Thrombocytopenia Pregnancy Lactation upto 6 months Hypertension Patient on anticoagulants.

结局指标

主要结局

reduction in pain intensity assessed by Visual Analogue Scale in each consecutive cycle

时间窗: Baseline day 0 | 4 weeks | 8 weeks | 12 weeks

次要结局

  • overall reduction in severity of dysmenorrhea & associated symptoms measured by WaLIDD Score(Baseline day 0)

研究者

发起方
Government Nizamia Tibbi College
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Dr Husna Begum

Government Nizamia Tibbi College

研究点 (1)

Loading locations...

相似试验